Literature DB >> 28446415

[Expressions of inflammatory and fibrogenic factors in perinephric and subcutaneous adipose tissues of patients with adrenocorticotropic hormone-independent Cushing's syndrome].

Chun-Yan Wu1, Hui-Jian Zhang, Cun-Xia Fan, Peng Wu, Qiang Wei, Ying-Ying Cai, Shao-Zhou Zou, Ling Wang, Yao-Ming Xue, Mei-Ping Guan.   

Abstract

OBJECTIVE: To investigate the expressions of inflammation- and fibrosis-related genes in perinephric and subcutaneous adipose tissues in patients with adrenocorticotropic hormone (ACTH)-independent Cushing's syndrome.
METHODS: The perinephric and subcutaneous adipose tissues adipose tissues were obtained from 8 patients with ACTH-independent Cushing's syndrome undergoing laparoscopic retroperitoneal adrenalectomy. Real-time PCR was used to detect the mRNA expression levels of interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α), matrix metallopeptidase 2 (MMP-2), TIMP metallopeptidase inhibitor 1 (TIMP-1), early growth response 1 (EGR1), CCAAT/enhancer binding protein β(CEBPβ), uncoupling protein 1(UCP-1), PPARγ coactivator 1 alpha (PGC1α) and cell death-inducing DFFA-like effector a (CIDEA).
RESULTS: The mRNA level of CIDEA was significantly higher in the perinephric adipose tissue (peri-N) than in the subcutaneous adipose tissue (subQ) (P<0.05). The expressions of CEBPβ, UCP-1, and PGC1α mRNA in the peri-N were similar with those in the subQ. The expressions of IL-6, TIMP1 and EGR1 mRNA in the subQ were significantly higher than those in the peri-N (P<0.05). No significant difference in TNF-α and MMP-2 mRNA levels was found between peri-N and subQ.
CONCLUSION: The expression levels of the inflammation- and fibrosis-related genes are higher in the subQ than in the peri-N of patients with ACTH-independent Cushing's syndrome, suggesting that chronic exposure to endogenous hypercortisolism may cause adipose tissue dysfunction.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28446415      PMCID: PMC6744092     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  23 in total

1.  Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.

Authors:  A Colao; R Pivonello; S Spiezia; A Faggiano; D Ferone; M Filippella; P Marzullo; G Cerbone; M Siciliani; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1999-08       Impact factor: 5.958

2.  Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in Cushing's disease. In vivo and in vitro studies.

Authors:  B Merola; S Longobardi; A Colao; C Di Somma; D Ferone; F Di Rella; R Pivonello; V Covelli; L Annunziato; G Lombardi
Journal:  Neuroendocrinology       Date:  1996-11       Impact factor: 4.914

3.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

4.  Modulation of early human preadipocyte differentiation by glucocorticoids.

Authors:  Julianna J Tomlinson; Adèle Boudreau; Dongmei Wu; Ella Atlas; Robert J G Haché
Journal:  Endocrinology       Date:  2006-07-27       Impact factor: 4.736

5.  Determination of UCP1 expression in subcutaneous and perirenal adipose tissues of patients with hypertension.

Authors:  Xueqin Li; Juan Liu; Gongcheng Wang; Jing Yu; Yunlu Sheng; Chen Wang; Yifan Lv; Shan Lv; Hanmei Qi; Wenjuan Di; Changjun Yin; Guoxian Ding
Journal:  Endocrine       Date:  2015-03-18       Impact factor: 3.633

6.  Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity.

Authors:  J Kopecky; G Clarke; S Enerbäck; B Spiegelman; L P Kozak
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

7.  Fibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health study.

Authors:  Isha Agarwal; Nicole L Glazer; Eddy Barasch; Mary L Biggs; Luc Djoussé; Annette L Fitzpatrick; John S Gottdiener; Joachim H Ix; Jorge R Kizer; Eric B Rimm; David S Siscovick; Russell P Tracy; Susan J Zieman; Kenneth J Mukamal
Journal:  Am J Epidemiol       Date:  2014-04-25       Impact factor: 4.897

8.  GH is a positive regulator of tumor necrosis factor alpha-induced adipose related protein in 3T3-L1 adipocytes.

Authors:  M Fasshauer; J Klein; S Krahlisch; U Lössner; M Klier; M Blüher; R Paschke
Journal:  J Endocrinol       Date:  2003-09       Impact factor: 4.286

9.  A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.

Authors:  Anna Vasků; Monika Goldbergová; Lydie Izakovicová Hollá; Lenka Sisková; Ladislav Groch; Michal Beránek; Svatava Tschöplová; Vladimír Znojil; Jirí Vácha
Journal:  Matrix Biol       Date:  2004-01       Impact factor: 11.583

Review 10.  Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.

Authors:  John Danesh; Stephen Kaptoge; Andrea G Mann; Nadeem Sarwar; Angela Wood; Sara B Angleman; Frances Wensley; Julian P T Higgins; Lucy Lennon; Gudny Eiriksdottir; Ann Rumley; Peter H Whincup; Gordon D O Lowe; Vilmundur Gudnason
Journal:  PLoS Med       Date:  2008-04-08       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.